Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of Trifluridine/Tipiracil in Combination With Irinotecan in Biliary Tract Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04072445
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:38.132632+00:00
Published At
2022-09-22T00:00:00+00:00
Record Updated At
2023-08-09
Results Posted At
2022-09-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Bile Duct Carcinoma", "Advanced Gallbladder Carcinoma", "Refractory Bile Duct Carcinoma", "Refractory Gallbladder Carcinoma", "Stage III Distal Bile Duct Cancer AJCC v8", "Stage III Gallbladder Cancer AJCC v8", "Stage III Intrahepatic Bile Duct Cancer AJCC v8", "Stage IIIA Distal Bile Duct Cancer AJCC v8", "Stage IIIA Gallbladder Cancer AJCC v8", "Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8", "Stage IIIB Distal Bile Duct Cancer AJCC v8", "Stage IIIB Gallbladder Cancer AJCC v8", "Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8", "Stage IV Distal Bile Duct Cancer AJCC v8", "Stage IV Gallbladder Cancer AJCC v8", "Stage IV Intrahepatic Bile Duct Cancer AJCC v8", "Stage IVA Gallbladder Cancer AJCC v8", "Stage IVB Gallbladder Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-09"
protocolSection.identificationModule.nctId
"NCT04072445"
protocolSection.identificationModule.officialTitle
"Phase II Trial of Trifluridine/Tipiracil in Combination With Irinotecan in Biliary Tract Cancers"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-09-22"

Study condition terms

  • Advanced Bile Duct Carcinoma (protocolSection.conditionsModule.conditions)
  • Advanced Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Bile Duct Carcinoma (protocolSection.conditionsModule.conditions)
  • Refractory Gallbladder Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Intrahepatic Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Distal Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Intrahepatic Bile Duct Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Gallbladder Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.